-
Jewish women dermatologists who escaped the perils of National Socialism: Triumph over adversity Clin. Dermatol. (IF 2.3) Pub Date : 2024-09-10 Sophie Walter BMed MD BSc(Med)(Hons), Lawrence Charles Parish MD MD (Hon) FRCP (Edin)
The period of National Socialism (1933-1945), including the Holocaust and World War II, has had a profound impact on dermatology. We have identified Jewish women dermatologists who escaped the perils of National Socialism, document their struggles, and describe their contribution to medicine and dermatology. Medical, history, and media databases were searched. Relevant contributions in languages other
-
Prevalence of tobacco use in patients with autoimmune blistering diseases: A nationwide, cross-sectional study Clin. Dermatol. (IF 2.3) Pub Date : 2024-08-13 Harrison Zhu BSA, Kritin K. Verma BS MBA, Katherine Holder MD, Stephen K. Tyring MD PhD MBA
-
From Reddit to reality: Investigating headache incidence in topical tretinoin users Clin. Dermatol. (IF 2.3) Pub Date : 2024-08-13 Kripa Ahuja MS, Peter Lio MD
-
Transforming dermatology through artificial intelligence and the Metaverse Clin. Dermatol. (IF 2.3) Pub Date : 2024-08-13 Mohamad Goldust MD, Marina Landau MD, Jane M. Grant-Kels MD
-
Characteristics and career outcomes of dermatology-focused medical student research grant recipients Clin. Dermatol. (IF 2.3) Pub Date : 2024-08-06 Grace Y. Duan MD, Zi-Yi Choo MD, Dima Kenj Halabi BS, Adena E. Rosenblatt MD PhD, Arlene M. Ruiz de Luzuriaga MD MPH MBA
Although several dermatology-focused research grants for medical students exist, studies have yet to evaluate the outcomes of grant recipients, such as entry into dermatology residency and academic careers. We have described the characteristics of recipients of dermatology-focused medical student research grants and outcomes, including entry into dermatology residency and academic careers, and we have
-
Screened out: Ethically managing sunscreen misinformation by social media influencers Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-27 Albert E. Zhou MD PhD, Nathan Gasek BS, Christian Gronbeck MD, Brett Sloan MD, Hao Feng MD MHS, Jane M. Grant-Kels MD
Rampant social media use allows individuals and organizations to broadcast their views to scoping audiences with minimal requirements for vetting or validating shared information. We discuss the impact of disinformation transmitted via social media and use the recent example of false information broadcast concerning sunscreens recently reported in the . We also highlight the ethical consequences of
-
Fostering unity and respect in dermatology: Navigating challenges and embracing growth Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-25 Kripa Ahuja MS, Peter Lio MD
-
Analysis of ichthyosis subreddit provides greater insight into disease Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-25 Kripa Ahuja MS, Anika Shah BS, Madeline Coleman BS, Peter Lio MD
-
A shift in tattoo trends among professional ATP tennis players Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-25 Nicolas Kluger MD
-
Response to “Revolutionizing teledermatology: Exploring the integration of AI, including GPT chatbots for AI-driven anamnesis, diagnosis, and treatment plans” Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-17 Jonathan Shapiro MD, Anna Lyakhovitsky MD
-
Ethics of residency programs and fellowships that electively withdraw from the National Resident Matching Program Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-16 Albert E. Zhou MD PhD, Bryan Carmody MD, Christian Gronbeck MD, Steven Angus MD, Brett Sloan MD, Hao Feng MD MHS, Jane M. Grant-Kels MD
The National Resident Matching Program, known as “The Match” facilitates the placement of medical graduates into residency and fellowship programs in the United States. Programs may opt out of The Match for various reasons. The selective and intermittent withdrawal of programs from The Match raises ethical concerns surrounding fairness, transparency, beneficence, autonomy, and justice for applicants
-
The role of the pediatric dermatologist in childhood bullying prevention and intervention: A call to action Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-15 Kripa Raj Ahuja MS, Peter A. Lio MD
-
Revolutionizing teledermatology: Exploring the integration of AI, including GPT chatbots for AI-driven anamnesis, diagnosis, and treatment plans: Correspondence Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-14 Hinpetch Daungsupawong MD, Viroj Wiwanitkit MD
-
Stepping out of the dollhouse and into inclusivity Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-14 Kripa Raj Ahuja MS, Peter Lio MD
-
Reply to “A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists” Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-08 Zachary Neubauer BS, Carrie Forman BS, Shari R. Lipner MD PhD
-
Letter to the editor in reply to “A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists” Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-06 Hossein Akbarialiabad MD MS, Jane M. Grant-Kels MD, Dedee F. Murrell BMBCh DSc
-
Antisemitism and dermatology in Nazi Germany and beyond Clin. Dermatol. (IF 2.3) Pub Date : 2024-07-06 Nikki R. Adler FACD, Jane M. Grant-Kels MD
Antisemitism, the hatred of or prejudice against Jews, was a core component of the Nazi regime's ideology. We review the chronology of events against the Jews and Jewish physicians in Germany and their conquered territories from 1933 to 1945. The complicit role that German physicians played in these events and the devastating impact on Jewish dermatologists and our specialty will be recounted. Finally
-
More than just dermatitis: The multifaceted nature of chronic itch through the historical perspective of Napoleon Bonaparte Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-28 Zachary Leibovit-Reiben BS, Hannah Godfrey BS, Alissa Stanley BS, Rebecca Thiede MD
Derived from the survival advantage needed to eradicate harmful irritants from the skin's surface, itch, also known as pruritus, is an intriguing phenomenon and a key feature of many dermatologic diseases. The pathologic form, chronic itch, is a condition that precedes itself by its complex pathophysiology, numerous etiologies, and interplay of mechanisms that often make it difficult to diagnose and
-
Underserved populations and health equity in dermatology: Digital medicine and the role of artificial intelligence Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-27 Eran C. Gwillim MD, Soraya Azzawi MD, Alyx Rosen Aigen MD
We have reviewed the current literature focused on the role of artificial intelligence (AI) for underserved populations and health equity in dermatology. Studies evaluating the utility and safety of AI model builds, and how they meet predefined benchmarks, as well as the clinical applications of AI, including decision-support systems and operational management, were the focus of this study. The seven
-
Frontal fibrosing alopecia—A new absolute contraindication for deep chemical peels Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-27 Marina Landau MD, Antonella Tosti MD, George Kroumpouzos MD PhD, Erik Eims MD, Mohamad Goldust MD
Frontal fibrosing alopecia (FFA) is characterized by a receding hairline in the frontotemporal region due to the gradual loss of hair follicles and then follicular stem cells and follicular fibrosis. Follicular stem cells are crucial in skin healing after chemical peeling and other resurfacing procedures. Although there is a possible association of FFA with a history of facial and scalp surgical procedures
-
Artificial Intelligence II Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-27 Leonard J. Hoenig MD, Vesna Petronic-Rosic MD MSc MBA, Franco Rongioletti MD
-
Revolutionizing teledermatology: Exploring the integration of artificial intelligence, including Generative Pre-trained Transformer chatbots for artificial intelligence-driven anamnesis, diagnosis, and treatment plans Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-27 Jonathan Shapiro MD, Anna Lyakhovitsky MD
The integration of teledermatology and artificial intelligence (AI) marks a significant advancement in dermatologic care. This study examines the synergistic interplay between these two domains, highlighting their collective impact on enhancing the accuracy, accessibility, and efficiency of teledermatologic services. Teledermatology expands dermatologic care to remote and underserved areas, and AI
-
Is artificial intelligence useful in the practice of geriatric dermatology? Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-26 Valencia Long MBBS MRCP (UK)
Geriatric dermatology has gained increasing importance through the years, alongside a steadily aging global population. Simultaneously, artificial intelligence (AI) technologies have become more advanced, and AI has been found to be useful in the general practice of dermatology. Whether or not and how AI can be useful in the practice of geriatric dermatology remains unanswered. We have explored the
-
Artificial intelligence and skin melanoma Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-26 Nick J. Levell MBChB MD FRCP MBA, Lucy Thomas MPharm MBChB MRCP(UK)
Melanoma is the deadliest skin cancer, presenting typically with changing pigmented areas and usually treated with surgical removal. As benign cutaneous pigmented lesions are very common in all populations, it can be challenging to identify which areas should be cut out or left untreated. Delayed treatment in melanoma increases the risk of death, but it is not possible to remove all lesions. Dermatoscopy
-
Artificial intelligence in dermatology: Bridging the gap in patient care and education Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-25 Nayyab Sohail BS, Carolina Puyana MD MSPH, Lacey Zimmerman MD, Maria M. Tsoukas MD PhD
The application of artificial intelligence (AI) in education and clinical medicine has shown tremendous growth. The primary explanation for this application is AI's ability to integrate efficient and tailored methods for screening, using diagnostics, and enhancement of patient and medical education. AI's wide scope of utility can be seen through its ability to improve efficiency in clinical settings
-
Legal implications of artificial intelligence in health care Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-25 Ana Rosic JD
The last few years have seen a boom in the popularity of artificial intelligence (AI) around the world, and the health care sector has not been immune from what has been perceived by some as a revolutionary technology. Although AI has been around for many years, including in the field of health care, the recent introduction of consumer-facing generative AI tools has put a spotlight on the technology
-
The potential role and restrictions of artificial intelligence in medical school dermatology education Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-24 Jahleel Perrin BS, Vesna Petronic-Rosic MD MSc MBA
Artificial intelligence (AI) is a rapidly developing field with the potential to transform various aspects of health care and public health, including medical training. The use of AI is still being studied to understand better how to integrate its innumerable applications into modern medicine and how it is taught. Medical school dermatology education in particular stands to benefit from AI, especially
-
Artificial intelligence for nonmelanoma skin cancer Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-24 Megan H. Trager MD, Emily R. Gordon BA, Alyssa Breneman MD, Chunhua Weng PhD, Faramarz H. Samie MDPhD
Nonmelanoma skin cancers (NMSCs) are among the top five most common cancers globally. NMSC is an area with great potential for novel application of diagnostic tools including artificial intelligence (AI). In this scoping review, we aimed to describe the applications of AI in the diagnosis and treatment of NMSC. Twenty-nine publications described AI applications to dermatopathology including lesion
-
Response to “Kaspar Hauser, the Child of Europe: Are smallpox vaccination scars the clue to a 2-century-old mystery?” Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-24 D. Pfründer MD
-
Rare and novel complications of botulinum neurotoxin type A and dermal filler injections Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-22 Marina Landau MD, Jerome Klein MD, Frank Rosengaus Leizgold MD, George Kroumpouzos MDPhD
Botulinum neurotoxin type A (BoNTA) and filler injection procedures usually provide predicted outcomes with a low incidence of complications. Most of the complications after these procedures have been extensively discussed. In this study, we report on these injectables’ less well-known, recently reported, and novel complications and attempt to clarify the underlying mechanisms. Counterfeit or mishandled
-
Artificial intelligence in autoimmune bullous dermatoses Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-22 Karen Manuelyan MDPhD, Miroslav Dragolov MD, Kossara Drenovska MDPhD, Martin Shahid MDPhD, Snejina Vassileva MDPhD
Dermatologists treating patients with autoimmune bullous dermatoses (AIBDs), as well as the patients themselves, encounter challenges at every stage of their interaction, including dermatologic and comorbidities assessment, diagnosis, prognosis evaluation, treatment, and follow-up monitoring. We summarize the current and potential future clinical applications of artificial intelligence (AI) in the
-
Improving data participation for the development of artificial intelligence in dermatology Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-21 Arlene Ruiz de Luzuriaga MD MPH MBA
Artificial intelligence (AI) has the potential to significantly impact many aspects of dermatology. The visual nature of dermatology lends itself to innovations in this space. The robustness of AI algorithms depends on the quality, quantity, and variety of data on which it is trained and tested. Image collections can suffer from inconsistencies in image quality, underrepresentation of various anatomic
-
The state of artificial intelligence for systemic dermatoses: Background and applications for psoriasis, systemic sclerosis, and much more Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-21 Advaitaa Ravipati MS, Scott A. Elman MD
Artificial intelligence (AI) has been steadily integrated into dermatology, with AI platforms already attempting to identify skin cancers and diagnose benign versus malignant lesions. Although not as widely known, AI programs have also been utilized as diagnostic and prognostic tools for dermatologic conditions with systemic or extracutaneous involvement, especially for diseases with autoimmune etiologies
-
Artificial intelligence in dermatopathology: Updates, strengths, and challenges Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-21 Gerardo Cazzato MD, Franco Rongioletti MD
Artificial intelligence (AI) has evolved to become a significant force in various domains, including medicine. We explore the role of AI in pathology, with a specific focus on dermatopathology and neoplastic dermatopathology. AI, encompassing machine learning and deep learning, has demonstrated its potential in tasks ranging from diagnostic applications on whole slide imaging to predictive and prognostic
-
Application of a natural language processing artificial intelligence tool in psoriasis: A cross-sectional comparative study on identifying affected areas in patients’ data Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-21 Jonathan Shapiro MD, Sharon Baum MD, Felix Pavlotzky MD, Yaron Ben Mordehai MD, Aviv Barzilai MD, Tamar Freud MD, Rotem Gershon MD
Psoriasis is an immune-mediated skin disease affecting approximately 3% of the global population. Proper management of this condition necessitates the assessment of the body surface area and the involvement of nails and joints. The integration of natural language processing with electronic medical records (EMRs) has recently shown promise in advancing disease classification and research. This study
-
Relevance and ethical issues of diversity equity and inclusion programs, circa 2024-2025 Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-19 Madeline Brown BS, Albert E. Zhou MD PhD, Neelesh P. Jain MD, Christian Gronbeck MD, Steven Brett Sloan MD, Jane M. Grant-Kels MD
A recent resolution with approximately 100 signatories entitled “Sunsetting All Diversity, Equity, and Inclusion (DEI) Programs” administered by the American Academy of Dermatology (AAD) sparked controversial debate within the field. Despite the AAD voting against the proposal to eliminate DEI initiatives, many underrepresented medical groups wondered how to move forward and create safe spaces for
-
Public perspective and knowledge of isotretinoin on Instagram Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-19 Kelly E. Owens BS, Khushnood Faraz BS, Simon W. Jiang MD, Caroline Gerhardt MD, Beiyu Liu PhD, Cynthia L. Green PhD, Matilda W. Nicholas MD PhD
-
Dermatology's ethical obligations to diversity, equity, and inclusion and antisemitism Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-18 Alana L. Ferreira BS, Yacine N. Sow BA, Jane M. Grant-Kels MD
In 2023-2024, a resolution was proposed to “sunset” the American Academy of Dermatology's Diversity, Equity, and Inclusion initiatives, citing concerns about stifling diversity of thought and promoting antisemitism. Although this resolution was ultimately withdrawn, there are many ethical issues surrounding this complex issue. Herein, we explore ways in which Diversity, Equity, and Inclusion and the
-
REMOVED: Doxxing and cyberbullying in dermatology Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-15 Albert E. Zhou MD PhD, Ishani H. Rao BS, Neelesh P. Jain MD, Christian Gronbeck MD, Brett Sloan MD, Jane M. Grant-Kels MD, Hao Feng MD MHS
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be specified, or the article will be reinstated.
-
Ethical issues of medical schools and their academic departments accepting gifts from pharma Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-14 Ayushya Ajmani BA, M. Shane Chapman MD MBA, Jane M. Grant-Kels MD
The ethical implications of medical schools or any of their academic departments accepting large corporate donations, mainly from pharmaceutical companies, have been long debated. Although such contributions are common in other graduate institutions, medical schools must be convinced about potential conflicts of interest and public opinion. We re-explore the benefits these kinds of gifts would afford
-
Higher detection of melanoma on the back in married men Clin. Dermatol. (IF 2.3) Pub Date : 2024-06-11 Eduardo Williams-Medina BA, Daniela Duarte-Bateman MD, Yanwen Chen MS PhD, Taylor Bullock MD, Brian R. Gastman MD
-
A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists Clin. Dermatol. (IF 2.3) Pub Date : 2024-05-31 Hossein Akbarialiabad MD MSc, Jane M. Grant-Kels MD, Dedee F. Murrell BMBCh DSc
Physicians and surgeons have a threefold increased risk of glioblastoma compared with population controls. We discuss the potential role of dermatology neurotoxin and carcinogenic occupational exposure, particularly to formalin/formaldehyde; how to reduce those exposures; and the ethical imperative for dermatologists to protect themselves, their staff, and their patients.
-
Ethics of patients losing insurance coverage due to hospital-insurer contract disagreements Frank H. Netter MD School of Medicine at QuinnipiacUniversity, North Haven, Conneticut Clin. Dermatol. (IF 2.3) Pub Date : 2024-05-20 Ishani Rao BS, Albert E. Zhou MD PhD, Neelesh P. Jain MD, Jane M. Grant-Kels MD
Despite most Americans having healthcare coverage, coverage does not equate to access. For many, healthcare coverage is being threatened by contractual disagreements between major health insurers and hospitals. In New York, in efforts to control costs, Aetna and United Healthcare have recently engaged in contentious contract negotiations with NewYork-Presbyterian and Mount Sinai medical centers, resulting
-
Ultrasonographic features of nonvascular complications of hyaluronic acid fillers: a retrospective study at a reference center for dermatologic ultrasonography Clin. Dermatol. (IF 2.3) Pub Date : 2024-05-18 Claudia Gonzalez MD, Valeria Duque-Clavijo MS, George Kroumpouzos MD PhD, Ana Maria Garcia Concha MD, Miguel Olmos Perez MD
Hyaluronic acid filler injections have been associated with early, temporary, and delayed-onset complications. High-resolution ultrasound with Doppler analysis has been increasingly used to detect and identify such complications. We comprehensively describe the most common ultrasonographic findings of nonvascular complications associated with hyaluronic acid filler injections. This retrospective, cross-sectional
-
Trends in consumer product–related contact dermatitis in hospital emergency departments, 2003-2022 Clin. Dermatol. (IF 2.3) Pub Date : 2024-05-17 Rishub K. Das MD, Karen Arnaud MD, Anna S. Clayton MD
-
Microneedling facial gone wrong: Navigating safety and regulation in the rise of medical spas Clin. Dermatol. (IF 2.3) Pub Date : 2024-05-17 Rachel Wetstone MD MPH, Jane M. Grant-Kels MD
-
Educational strategies to combat harmful cosmetic dermatology trends in Generations Alpha and Z Clin. Dermatol. (IF 2.3) Pub Date : 2024-05-16 Diala Haykal MD, Hugues Cartier MD, George Kroumpouzos MD PhD
This contribution argues in favor of implementing comprehensive educational strategies to combat the harmful effects of social media (SM) on body image and self-perception among Generations Alpha and Z. These generations are often exposed to unattainable beauty standards that can lead to distorted self-perceptions and body image disorders such as Zoom dysmorphia. To address this issue, we propose embedding
-
Upholding the principle of “do no harm” in esthetics Clin. Dermatol. (IF 2.3) Pub Date : 2024-05-10 Mohamad Goldust MD, Marina Landau MD, Jane M. Grant-Kels MD
-
Hidradenitis suppurativa from the typical patient to the new clinical phenotype Clin. Dermatol. (IF 2.3) Pub Date : 2024-05-05 Nimra Masood MD
-
The ethics of full body skin examinations Clin. Dermatol. (IF 2.3) Pub Date : 2024-04-30 Jane M. Grant-Kels MD
Full body skin examinations (FBSEs) are part of the purview of a dermatologic examination. Because this involves examination of sensitive or intimate areas, there are many ethical issues involved. Herein, we discuss whether screening patients with an FBSE is ethical and consistent with the ethical tenet of distributive justice, how to ethically deal with our patients with disabilities, how to ethically
-
Role of physician extenders in resident education and dermatology practice Clin. Dermatol. (IF 2.3) Pub Date : 2024-04-26 Albert E. Zhou MD PhD, Christian Gronbeck MD, Neelesh Jain MD, Donna Aiudi MD, Jane M. Grant-Kels MD
-
Cosmetic skin lightening: Contextualizing biomedical and ethical issues Clin. Dermatol. (IF 2.3) Pub Date : 2024-04-13 James Bradley M. Parente BA, Genevieve S. Silva BS, Jeromy W. Gotschall BA, Alana L. Ferreira BA, Jane M. Grant-Kels MD
The skin-lightening (SL) industry has a global reach and is projected to continue to grow over the coming decade. Although SL treatments may be safely prescribed for the treatment of some dermatologic conditions, many over-the-counter SL products contain ingredients that can cause harm to the skin and other organ systems. Given a lack of transparent information to patients and the historical colorist
-
Is it ethical to lie by omission for a patient? Clin. Dermatol. (IF 2.3) Pub Date : 2024-02-23 Krishan Parashar BS, Jane M. Grant-Kels MD, Abraham M. Korman MD
In the age of increasing transparency, dermatologists may encounter requests from patients to alter or withhold key medical information from their electronic medical records. Per the Health Insurance Portability and Accountability Act, patients have the right to view their medical record and request amendments; however, the physician is the final decision maker on what information should be included
-
Balancing ethical principles in dermatology: Disclosing clinical trial underrepresentation during informed consent Clin. Dermatol. (IF 2.3) Pub Date : 2024-02-23 Alana Ferreira, Jeromy W. Gotschall, Jane M. Grant-Kels MD
-
Ethics of artificial intelligence in dermatology Clin. Dermatol. (IF 2.3) Pub Date : 2024-02-23 Maggie Chen BS, Albert E. Zhou MD PhD, Neelesh Jain MD, Christian Gronbeck MD, Hao Feng MD, Jane M. Grant-Kels MD
The integration of artificial intelligence (AI) in dermatology holds promise for enhancing clinical accuracy, enabling earlier detection of skin malignancies, suggesting potential management of skin lesions and eruptions, and promoting improved continuity of care. AI implementation in dermatology, however, raises several ethical concerns. This review explores the current benefits and challenges associated
-
Persian Contributions to Dermatology Clin. Dermatol. (IF 2.3) Pub Date : 2024-02-23 Mohamad Goldust MD, Marina Landau MD, Jane M. Grant-Kels MD
-
The global burden of HIV Clin. Dermatol. (IF 2.3) Pub Date : 2024-02-21 Sashini Payagala MB BS, Anton Pozniak MD FRCP
The global burden of HIV remains a formidable challenge, affecting millions. Despite significant progress in understanding, treatment, and prevention , HIV/AIDS continues to exert a substantial impact on personal and public health, particularly in sub-Saharan Africa, where the prevalence is highest. HIV not only poses a direct threat to the well-being of individuals but also contributes to social and
-
-
-
Eponyms that honor Jewish dermatologists: A celebration and a remembrance, Part three: Jewish physicians who practiced during the Holocaust and in its aftermath Clin. Dermatol. (IF 2.3) Pub Date : 2024-02-09 Leonard J. Hoenig MD, Dan Lipsker, Lawrence Charles Parish MD MD (Hon) FRCP (Edin)
Part III of this contribution continues to celebrate the many contributions that Jewish physicians have made to advance the specialty of dermatology, as reflected by eponyms that honor their names. Part I covered the years before 1933, a highly productive period of creativity by Jewish dermatologists, especially in Germany and Austria. The lives of 17 Jewish physicians and their eponyms were described